Epigenomic analysis by Benjamin Ziman et al. found that FOXM1 plays an important role in the development of esophageal adenocarcinoma and regulates anti-tumor immune response in esophageal adenocarcinoma (Ziman et al., 2024). This evidence concerns the gene FOXM1 and esophageal adenocarcinoma.